M. Pellowska

Molecular pharmacological profile of a novel thiazolinone‐based direct and selective 5‐lipoxygenase inhibitor

G. Schneider, H. Stark, D. Steinhilber, 2012, British journal of pharmacology.

Pharmacokinetic properties of MH84, a γ-secretase modulator with PPARγ agonistic activity.

M. Schubert-Zsilavecz, M. Wurglics, D. Merk, 2015, Journal of pharmaceutical and biomedical analysis.

A pirinixic acid derivative (LP105) inhibits murine 5‐lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm

D. Steinhilber, M. Schubert-Zsilavecz, M. Wurglics, 2011, British journal of pharmacology.

MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease

M. Schubert-Zsilavecz, M. Wurglics, M. Pellowska, 2018, Alzheimer's Research & Therapy.

MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease

M. Schubert-Zsilavecz, M. Wurglics, M. Pellowska, 2018, Alzheimer's Research & Therapy.

MH84: A Novel γ-Secretase Modulator/PPARγ Agonist—Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer’s Disease

M. Schubert-Zsilavecz, M. Wurglics, M. Pellowska, 2016, Neurochemical Research.

Advances in personalized medicine - medicinal chemistry and pharmacology of vemurafenib and ivacaftor.

M. Schubert-Zsilavecz, D. Merk, M. Pellowska, 2013, Pharmazie.